Abstract:Objective To explore the different clinical characteristics and risk factors between severely and critically ill children with novel H1N1 influenza for the guidance of the prophylaxis and therapy clinically.Methods Seventy-six cases with novel H1N1 influenza admitted during Oct.1 to Dec.15,2009 were divided into the severe group(n = 60)and the critical group(n = 16)according to the third edition guideline established by the Ministry of Health,and the clinical features were compared between two groups.Results The average age of severe cases(2.91 ± 2.26 y)was significantly younger than that of critical cases(4.68 ± 4.35 y)(P 0.05),and the mean length of hospital stay in the severe cases(7.75 ± 3.06 d)was significantly shorter than that in the critical cases(19.6 ± 7.72 d)(P 0.05).The common pathogens of the mixed bacterial infection were Streptococcus pneumoniae in the severe cases and Staphylococcus aureus in the critical cases,respectively.There were 31.6% of the severe cases and 56.3% of the critical cases to have the coexistence of the underlying disease(P 0.05).The most common underlying diseases were asthma and iron deficiency anemia in the severe cases,and iron deficiency anemia,cerebral palsy and congenital heart disease in the critical cases,respectively.The oxygenation index(PaO2/FiO2)in the severe cases(307.18 ± 55.73)was significantly higher compared to that in the critical cases(187.50 ± 73.62)(P 0.05).The levels of the serum prealbumin(PA)and albumin(A)were significantly higher in the severe cases than those in the critical cases,while the levels of the creatine kinase(CK),cardiac troponins I(cTnI),aspartate aminotransferase(AST),lactate dehydrogenase(LDH),α-hydroxybutyric acid(α-HBDH)and C-reactive protein(CRP)in the severe cases were significantly lower than those in the critical cases(P 0.05 for all).The severe cases had lower score of admission Pediatric Risk of Mortality III(PRISM III)and higher Pediatrics Critical Illness Score(PCIS)compared to critical cases(P 0.05).Conclusions The critical cases with novel H1N1 influenza are commonly older than the severe cases,and usually with more organs injuried.It will be helpful to undertake the laboratory tests(such as PaO2/FiO2 and CK,etc.),imaging examination,PRISM III score and PCIS score for the evaluation of the disease severity and prognosis.More attention ought to be paid to the children with iron deficiency anemia,cerebral palsy or congenital heart disease in order to prevent their conversion from severe cases to critical cases.The choice of antibiotics shall be made based on the difference in the bacterial spectrum of the mixed infection between the severe and critical cases.

Changes of Serum Complement Components C3,C4 and CH50 in 392 Patients with H1N1 Influenza A

Changes and significances of cytokines and immunoglobulin in serum in children with hand-foot-mouth disease

Changes in peripheral immunocytes and cytokines in patients with HIN1 influenza A virus infection

Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.

Changes and clinical values of serum high-sensitivity C reaction protein in patients with pandemic influenza A(H1N1)

Dynamic Variations in the Peripheral Blood Lymphocyte Subgroups of Patients with 2009 Pandemic H1N1 Swine-Origin Influenza A Virus Infection

Clinical Analysis of Severe Influenza A/H1N1 in 53 Patients

Epidemiological and Immunological Features of Influenza Viruses in Hospitalized Children with Influenza Illness in Hangzhou

Clinical Features of Severe Influenza A (H1N1) Virus Infection

Difference of Immunological and Inflammatory Indices Between Mild Type and Severe Type of Adult Pandemic(h1n1)patients

Immunological Markers in Patients with Influenza A(H1N1)

Dynamic Changes of T Cell Subgroup in Patients with Influenza A(H1N1) Infection

Clinical and Laboratory Features and Prognosis of 418 Patients with Influenza A(H1N1)

The need for strengthening the influenza virus detection ability of hospital clinical laboratories: an investigation of the 2009 pandemic

Immune derangement occurs in patients with H7N9 avian influenza

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

Lymphocyte Subpopulation and CD4~+CD25~+Treg Signature Analysis of Patients with Severe Influenza A(H1N1) Virus Infection

Clinical Study on Serum Myocardial Enzymes in Patients with H1N1 Influenza A Virus Infection

Angiotensin II Plasma Levels Are Linked to Disease Severity and Predict Fatal Outcomes in H7N9-infected Patients.

Comparasion of Clinical Characteristics Between Severely and Critically Ill Children with Novel H1N1 Influenza

Intensive Cytokine Induction In Pandemic H1n1 Influenza Virus Infection Accompanied By Robust Production Of Il-10 And Il-6